These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34679357)

  • 1. Role of COMT V158M Polymorphism in the Development of Dystonia after Administration of Antipsychotic Drugs.
    Nicotera AG; Di Rosa G; Turriziani L; Costanzo MC; Stracuzzi E; Vitello GA; Rando RG; Musumeci A; Vinci M; Musumeci SA; Calì F
    Brain Sci; 2021 Sep; 11(10):. PubMed ID: 34679357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association study of polymorphisms in DAT, DRD2, and COMT genes and acute extrapyramidal adverse effects in male schizophrenic patients treated with haloperidol.
    Zivković M; Mihaljević-Peles A; Bozina N; Sagud M; Nikolac-Perkovic M; Vuksan-Cusa B; Muck-Seler D
    J Clin Psychopharmacol; 2013 Oct; 33(5):593-9. PubMed ID: 23963056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine metabolism in adults with 22q11 deletion syndrome, with and without schizophrenia--relationship with COMT Val¹⁰⁸/¹⁵⁸Met polymorphism, gender and symptomatology.
    Boot E; Booij J; Abeling N; Meijer J; da Silva Alves F; Zinkstok J; Baas F; Linszen D; van Amelsvoort T
    J Psychopharmacol; 2011 Jul; 25(7):888-95. PubMed ID: 21447540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of COMT Val158Met polymorphism in Eastern UP population.
    Kumar P; Yadav U; Rai V
    Cell Mol Biol (Noisy-le-grand); 2017 Jul; 63(6):21-24. PubMed ID: 28968204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation.
    Dauvilliers Y; Tafti M; Landolt HP
    Sleep Med Rev; 2015 Aug; 22():47-53. PubMed ID: 25466290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients].
    Díez-Martín J; Hoenicka J; Martínez I; Aragüés M; Rodríguez-Jiménez R; Jiménez-Arriero MA; Ponce G; Rubio G; Palomo T;
    Med Clin (Barc); 2007 Jan; 128(2):41-4. PubMed ID: 17266899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between the Val158Met polymorphism of the catechol-O-methyl transferase gene and morphological abnormalities of the brain in chronic schizophrenia.
    Ohnishi T; Hashimoto R; Mori T; Nemoto K; Moriguchi Y; Iida H; Noguchi H; Nakabayashi T; Hori H; Ohmori M; Tsukue R; Anami K; Hirabayashi N; Harada S; Arima K; Saitoh O; Kunugi H
    Brain; 2006 Feb; 129(Pt 2):399-410. PubMed ID: 16330500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between catechol-O-methyltransferase (COMT) Val108/158Met and brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in age at onset and clinical symptoms in schizophrenia.
    Numata S; Ueno S; Iga J; Yamauchi K; Hongwei S; Kinouchi S; Shibuya-Tayoshi S; Tayoshi S; Aki H; Sumitani S; Itakura M; Ohmori T
    J Neural Transm (Vienna); 2007 Feb; 114(2):255-9. PubMed ID: 16897602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of COMT Val108/158Met genotype on risk for polydipsia in chronic patients with schizophrenia.
    Yamada K; Shinkai T; Chen HI; Utsunomiya K; Nakamura J
    Neuromolecular Med; 2014 Jun; 16(2):398-404. PubMed ID: 24443099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients.
    Al-Asmary S; Kadasah S; Arfin M; Tariq M; Al-Asmari A
    Genet Mol Res; 2014 Apr; 13(2):3079-88. PubMed ID: 24782165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.
    Apud JA; Weinberger DR
    CNS Drugs; 2007; 21(7):535-57. PubMed ID: 17579498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COMT val158met polymorphism and molecular alterations in the human dorsolateral prefrontal cortex: Differences in controls and in schizophrenia.
    Shukla AA; Jha M; Birchfield T; Mukherjee S; Gleason K; Abdisalaam S; Asaithamby A; Adams-Huet B; Tamminga CA; Ghose S
    Schizophr Res; 2016 May; 173(1-2):94-100. PubMed ID: 27021555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Schizophrenia-like neurophysiological abnormalities in 22q11.2 deletion syndrome and their association to COMT and PRODH genotypes.
    Zarchi O; Carmel M; Avni C; Attias J; Frisch A; Michaelovsky E; Patya M; Green T; Weinberger R; Weizman A; Gothelf D
    J Psychiatr Res; 2013 Nov; 47(11):1623-9. PubMed ID: 23910792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catechol-O-methyltransferase val108/158met genotype predicts working memory response to antipsychotic medications.
    Weickert TW; Goldberg TE; Mishara A; Apud JA; Kolachana BS; Egan MF; Weinberger DR
    Biol Psychiatry; 2004 Nov; 56(9):677-82. PubMed ID: 15522252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrogating the Relationship Between Schizotypy, the Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism, and Neuronal Oscillatory Activity.
    Steiner GZ; Fernandez FM; Coles M; Karamacoska D; Barkus E; Broyd SJ; Solowij N; Watson OT; Chiu CL; Lind JM; Barry RJ
    Cereb Cortex; 2019 Jul; 29(7):3048-3058. PubMed ID: 30084963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between catechol-O-methyltransferase (COMT) Val158Met genotype and genetic vulnerability to schizophrenia during explicit processing of aversive facial stimuli.
    Lo Bianco L; Blasi G; Taurisano P; Di Giorgio A; Ferrante F; Ursini G; Fazio L; Gelao B; Romano R; Papazacharias A; Caforio G; Sinibaldi L; Popolizio T; Bellantuono C; Bertolino A
    Psychol Med; 2013 Feb; 43(2):279-92. PubMed ID: 22617427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome.
    Karling P; Danielsson Å; Wikgren M; Söderström I; Del-Favero J; Adolfsson R; Norrback KF
    PLoS One; 2011 Mar; 6(3):e18035. PubMed ID: 21437260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between catechol-O-methyltransferase gene Val158Met (COMT) polymorphism and premorbid cannabis use in Turkish male patients with schizophrenia.
    Ermis A; Erkiran M; Dasdemir S; Turkcan AS; Ceylan ME; Bireller ES; Cakmakoglu B
    In Vivo; 2015; 29(1):129-32. PubMed ID: 25600541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COMT Val(158)Met genotype determines the direction of cognitive effects produced by catechol-O-methyltransferase inhibition.
    Farrell SM; Tunbridge EM; Braeutigam S; Harrison PJ
    Biol Psychiatry; 2012 Mar; 71(6):538-44. PubMed ID: 22364739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.